PFM Health Sciences’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
+1,238,846
| New | +$20.8M | 1.77% | 19 |
|
|
2025
Q1 | – | Sell |
-397,024
| Closed | -$8.75M | – | 83 |
|
|
2024
Q4 | $8.75M | Buy |
+397,024
| New | +$8.75M | 0.54% | 38 |
|
|
2020
Q3 | – | Sell |
-2,034,296
| Closed | -$25.1M | – | 83 |
|
|
2020
Q2 | $25.1M | Buy |
+2,034,296
| New | +$25.1M | 1.3% | 28 |
|
|
2016
Q1 | – | Sell |
-1,860,952
| Closed | -$122M | – | 89 |
|
|
2015
Q4 | $122M | Buy |
1,860,952
+322,087
| +21% | +$21.1M | 3.71% | 6 |
|
|
2015
Q3 | $86.9M | Buy |
1,538,865
+329,901
| +27% | +$18.6M | 2.44% | 13 |
|
|
2015
Q2 | $71.5M | Buy |
1,208,964
+410,267
| +51% | +$24.2M | 1.81% | 21 |
|
|
2015
Q1 | $49.8M | Sell |
798,697
-1,303,739
| -62% | -$81.2M | 1.37% | 32 |
|
|
2014
Q4 | $121M | Sell |
2,102,436
-64,233
| -3% | -$3.69M | 2.82% | 6 |
|
|
2014
Q3 | $116M | Sell |
2,166,669
-1,352,381
| -38% | -$72.7M | 2.68% | 14 |
|
|
2014
Q2 | $184M | Buy |
3,519,050
+99,697
| +3% | +$5.23M | 3.69% | 8 |
|
|
2014
Q1 | $181M | Buy |
+3,419,353
| New | +$181M | 3.28% | 8 |
|